Clinical Trial: Safety and Tolerability Evaluation of IgG Binding Protein LT

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07824011) titled 'Safety and Tolerability Evaluation of IgG Binding Protein LT' on Sept. 11.

Brief Summary: This study evaluates the safety and tolerability of the food ingredient IgG Binding Protein LT (BP-LT) when added to a daily diet. BP-LT is a stable protein ingredient being functional in the gastrointestinal tract and without systemic absorption. This registration covers a decentralized, randomized, double-blind, placebo-controlled clinical study evaluating BP-LT in healthy adults.

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Safety and Tolerability in Healthy Volunteers

Intervention: DIETARY_SUPPLEMENT: IgG Binding P...